Myasthenia gravis and COVID-19: A case series and comparison with literature.

ABSTRACT:

Objective

To describe presenting symptoms, clinical outcomes, and therapeutic management of concurrent Coronavirus disease 2019 (COVID-19) infections in patients with a pre-existing myasthenia gravis (MG).

Methods

We conducted a retrospective study in patients with preexisting MG presenting with concurrent COVID-19 between September 21st and November 4th, 2020 when attending the emergency department or routine neurology consultation at the National Institute Mongi Ben Hamida of Neurology of Tunis, Tunisia.

Results

Five patients were identified. The Myasthenia Gravis Foundation of America scores (MGFA) prior to COVID-19 infection were class I in one patient, class II (IIa, IIb) in two patients, and class IIIb in one patient. Four patients had mild to moderate courses o

SUBMITTER: Saied Z 

PROVIDER: S-EPMC8222886 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature